Nomura Asset Management Co. Ltd. raised its holdings in Pediatrix Medical Group, Inc. (NYSE:MD – Free Report) by 95.3% during the 4th quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 2,500 shares of the company’s stock after buying an additional 1,220 shares during the period. Nomura Asset Management Co. Ltd.’s holdings in Pediatrix Medical Group were worth $33,000 at the end of the most recent quarter.
A number of other hedge funds also recently made changes to their positions in MD. Everence Capital Management Inc. boosted its holdings in shares of Pediatrix Medical Group by 7.5% during the 4th quarter. Everence Capital Management Inc. now owns 13,840 shares of the company’s stock worth $182,000 after buying an additional 960 shares during the period. Parkside Financial Bank & Trust grew its position in shares of Pediatrix Medical Group by 36.1% in the fourth quarter. Parkside Financial Bank & Trust now owns 3,919 shares of the company’s stock valued at $51,000 after purchasing an additional 1,040 shares during the last quarter. Quarry LP increased its stake in shares of Pediatrix Medical Group by 54.1% during the third quarter. Quarry LP now owns 4,735 shares of the company’s stock worth $55,000 after purchasing an additional 1,662 shares during the period. AlphaQuest LLC lifted its holdings in Pediatrix Medical Group by 65.9% during the 4th quarter. AlphaQuest LLC now owns 5,066 shares of the company’s stock worth $66,000 after purchasing an additional 2,012 shares during the last quarter. Finally, Illinois Municipal Retirement Fund boosted its stake in Pediatrix Medical Group by 7.8% in the 4th quarter. Illinois Municipal Retirement Fund now owns 47,409 shares of the company’s stock valued at $622,000 after purchasing an additional 3,411 shares during the period. 97.71% of the stock is owned by institutional investors and hedge funds.
Wall Street Analysts Forecast Growth
A number of equities research analysts have recently weighed in on MD shares. Truist Financial lifted their target price on Pediatrix Medical Group from $15.00 to $18.00 and gave the stock a “hold” rating in a report on Friday, February 21st. StockNews.com raised shares of Pediatrix Medical Group from a “hold” rating to a “buy” rating in a report on Wednesday, January 22nd. Macquarie assumed coverage on shares of Pediatrix Medical Group in a report on Monday, December 16th. They set an “outperform” rating and a $18.00 target price on the stock. Finally, UBS Group boosted their price target on Pediatrix Medical Group from $16.50 to $18.50 and gave the company a “neutral” rating in a research note on Friday, February 21st. Four investment analysts have rated the stock with a hold rating and three have assigned a buy rating to the company. Based on data from MarketBeat, the company presently has a consensus rating of “Hold” and an average target price of $17.08.
Pediatrix Medical Group Stock Down 4.8 %
NYSE MD opened at $13.46 on Friday. The business has a fifty day moving average price of $14.42 and a two-hundred day moving average price of $13.77. The stock has a market capitalization of $1.16 billion, a PE ratio of -11.22, a PEG ratio of 1.74 and a beta of 1.49. Pediatrix Medical Group, Inc. has a fifty-two week low of $6.62 and a fifty-two week high of $17.67. The company has a debt-to-equity ratio of 0.81, a current ratio of 1.60 and a quick ratio of 1.42.
Pediatrix Medical Group (NYSE:MD – Get Free Report) last announced its quarterly earnings data on Thursday, February 20th. The company reported $0.49 earnings per share for the quarter, topping the consensus estimate of $0.37 by $0.12. Pediatrix Medical Group had a positive return on equity of 15.47% and a negative net margin of 4.92%. The business had revenue of $502.36 million during the quarter, compared to the consensus estimate of $486.22 million. Equities analysts expect that Pediatrix Medical Group, Inc. will post 1.38 earnings per share for the current fiscal year.
Pediatrix Medical Group Company Profile
Pediatrix Medical Group, Inc, together with its subsidiaries, provides newborn, maternal-fetal, pediatric cardiology, and other pediatric subspecialty care services in the United States. It offers neonatal care services, such as clinical care to babies born prematurely or with complications within specific units at hospitals through neonatal physician subspecialists, neonatal nurse practitioners, and other pediatric clinicians.
Featured Stories
- Five stocks we like better than Pediatrix Medical Group
- How to Short Nasdaq: An Easy-to-Follow Guide
- Archer Aviation’s Africa Deal Could Boost ACHR Stock
- How to Invest in Tech Stocks and Top Tech Stocks to Consider
- Are Short Sellers Wrong About These 3 Semiconductor Stocks?
- Investing in Construction Stocks
- Boeing Gets $50B in March Orders—Is BA Stock a Buy Now?
Want to see what other hedge funds are holding MD? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Pediatrix Medical Group, Inc. (NYSE:MD – Free Report).
Receive News & Ratings for Pediatrix Medical Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Pediatrix Medical Group and related companies with MarketBeat.com's FREE daily email newsletter.